254 related articles for article (PubMed ID: 29046150)
1. Complex Interplay Between Solubilization, Digestion, Supersaturation and Absorption of Poorly Soluble Drugs with Lipid-Based Formulations.
Jannin V
Curr Drug Deliv; 2018; 15(6):749-751. PubMed ID: 29046150
[No Abstract] [Full Text] [Related]
2. Lipid-based formulations for oral administration of poorly water-soluble drugs.
Mu H; Holm R; Müllertz A
Int J Pharm; 2013 Aug; 453(1):215-24. PubMed ID: 23578826
[TBL] [Abstract][Full Text] [Related]
3. Rapid determination of drug solubilization versus supersaturation in natural and digested lipids.
Gautschi N; Bergström CA; Kuentz M
Int J Pharm; 2016 Nov; 513(1-2):164-174. PubMed ID: 27609663
[TBL] [Abstract][Full Text] [Related]
4. Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.
Williams HD; Trevaskis NL; Yeap YY; Anby MU; Pouton CW; Porter CJ
Pharm Res; 2013 Dec; 30(12):2976-92. PubMed ID: 23824582
[TBL] [Abstract][Full Text] [Related]
5. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
[TBL] [Abstract][Full Text] [Related]
6. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
Suys EJA; Chalmers DK; Pouton CW; Porter CJH
Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
[TBL] [Abstract][Full Text] [Related]
7. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
Porter CJ; Trevaskis NL; Charman WN
Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
[TBL] [Abstract][Full Text] [Related]
8. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.
Cherniakov I; Domb AJ; Hoffman A
Expert Opin Drug Deliv; 2015 Jul; 12(7):1121-33. PubMed ID: 25556987
[TBL] [Abstract][Full Text] [Related]
9. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
[TBL] [Abstract][Full Text] [Related]
10. Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.
Rezhdo O; Speciner L; Carrier R
J Control Release; 2016 Oct; 240():544-560. PubMed ID: 27520734
[TBL] [Abstract][Full Text] [Related]
11. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
Silva AC; Santos D; Ferreira D; Lopes CM
Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
[TBL] [Abstract][Full Text] [Related]
12. Nanonization techniques to overcome poor water-solubility with drugs.
Da Silva FLO; Marques MBF; Kato KC; Carneiro G
Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
[TBL] [Abstract][Full Text] [Related]
13. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
14. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
O'Driscoll CM; Griffin BT
Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
[TBL] [Abstract][Full Text] [Related]
15. Lipid-based systems for the enhanced delivery of poorly water soluble drugs.
Porter CJ; Wasan KM; Constantinides P
Adv Drug Deliv Rev; 2008 Mar; 60(6):615-6. PubMed ID: 18160174
[No Abstract] [Full Text] [Related]
16. Digestion of Lipid-Based Formulations Not Only Mediates Changes to Absorption of Poorly Soluble Drugs Due to Differences in Solubilization But Also Reflects Changes to Thermodynamic Activity and Permeability.
Tanaka Y; Nguyen TH; Suys EJA; Porter CJH
Mol Pharm; 2021 Apr; 18(4):1768-1778. PubMed ID: 33729806
[TBL] [Abstract][Full Text] [Related]
17. Factors and dosage formulations affecting the solubility and bioavailability of P-glycoprotein substrate drugs.
Murakami T; Bodor E; Bodor N
Expert Opin Drug Metab Toxicol; 2021 May; 17(5):555-580. PubMed ID: 33703995
[No Abstract] [Full Text] [Related]
18. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
Miller JM; Beig A; Carr RA; Spence JK; Dahan A
Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
[TBL] [Abstract][Full Text] [Related]
19. Advances in Polymer Design for Enhancing Oral Drug Solubility and Delivery.
Ting JM; Porter WW; Mecca JM; Bates FS; Reineke TM
Bioconjug Chem; 2018 Apr; 29(4):939-952. PubMed ID: 29319295
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
